AdisInsight profiles relating to the Zika virus are now available to access for free, as part of Springer Nature’s pledge to share data that can support public health emergencies.
Springer Nature is part of a group of leading global health bodies including academic journals, NGOs, research funders and institutes that published a joint statement earlier this year, committing to share data and results relevant to the current Zika crisis and future public health emergencies.
In line with this, Springer Nature is opening up its resources related to the Zika virus to help students, researchers, health care professionals, and other scientifically minded individuals to better understand the multidisciplinary approach to containing the virus and caring for patients.
We’ve included open-access links to drug profiles and clinical trial profiles from AdisInsight relevant to the Zika virus:
Additional research has been organized into various disciplines and made freely available – this includes articles, commentaries, blog posts and news items. To view all of the content available, please visit the landing page.
If you are interested in learning more about AdisInsight, please complete your details in the form and one of our colleagues will be in touch